Stay updated on EurofarmavsAlenia in Asthma and COPD Treatment Clinical Trial
Sign up to get notified when there's something new on the EurofarmavsAlenia in Asthma and COPD Treatment Clinical Trial page.

Latest updates to the EurofarmavsAlenia in Asthma and COPD Treatment Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has undergone significant updates, including the removal of detailed study descriptions and criteria for a clinical trial on asthma treatment, while retaining some core information about the study's design and objectives.SummaryDifference38%
- Check38 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 14, 2025.SummaryDifference0.6%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page has been updated to reflect new study dates and the removal of previous study details, including contact information for study personnel. Notably, the study titled 'A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment (ESPIRE)' has been removed.SummaryDifference8%
- Check96 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to EurofarmavsAlenia in Asthma and COPD Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EurofarmavsAlenia in Asthma and COPD Treatment Clinical Trial page.